Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nodular Basal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05157763
What this trial is testing

Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

Who this might be right for
Superficial Basal Cell CarcinomaNodular Basal Cell Carcinoma
MediWound Ltd 32
Not applicableWithdrawnNCT04510727
What this trial is testing

Optical Coherence Tomography Guided C&D

Who this might be right for
Basal Cell Carcinoma
University of Miami
Testing effectiveness (Phase 2)Study completedNCT04470726
What this trial is testing

Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype

Who this might be right for
Superficial Basal Cell CarcinomaNodular Basal Cell CarcinomaNonmelanoma Skin Cancers
AiViva BioPharma, Inc. 26
Testing effectiveness (Phase 2)Ended earlyNCT01033019
What this trial is testing

To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)

Who this might be right for
Sporadic Superficial and Nodular Skin Basal Cell Carcinomas
Novartis Pharmaceuticals 25
Large-scale testing (Phase 3)UnknownNCT02242929
What this trial is testing

Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma

Who this might be right for
Nodular Basal Cell Carcinoma
Maastricht University Medical Center 145
Testing effectiveness (Phase 2)Study completedNCT06608238
What this trial is testing

Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma.

Who this might be right for
Nodular Basal Cell Carcinoma
SkinJect, Inc. 90
Not applicableNot Yet RecruitingNCT07384078
What this trial is testing

High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults

Who this might be right for
Superficial Basal Cell CarcinomaNodular Basal Cell CarcinomaBowen's Disease+2 more
Jussi Salonen 294
Testing effectiveness (Phase 2)Study completedNCT02828111
What this trial is testing

Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinomas
PellePharm, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT01700049
What this trial is testing

Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes

Who this might be right for
Basal Cell Carcinoma
Mayo Clinic 28
Large-scale testing (Phase 3)Study completedNCT00472043
What this trial is testing

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma

Who this might be right for
Basal Cell Carcinoma
Galderma R&D 66